Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Neuroone Medical Technologies (NMTC) Assets Average (2016 - 2025)

Historic Assets Average for Neuroone Medical Technologies (NMTC) over the last 11 years, with Q4 2025 value amounting to $9.7 million.

  • Neuroone Medical Technologies' Assets Average rose 6320.48% to $9.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $9.7 million, marking a year-over-year increase of 6320.48%. This contributed to the annual value of $8.1 million for FY2025, which is 1996.2% up from last year.
  • Latest data reveals that Neuroone Medical Technologies reported Assets Average of $9.7 million as of Q4 2025, which was up 6320.48% from $10.8 million recorded in Q3 2025.
  • Neuroone Medical Technologies' Assets Average's 5-year high stood at $15.6 million during Q1 2022, with a 5-year trough of $5.1 million in Q3 2024.
  • For the 5-year period, Neuroone Medical Technologies' Assets Average averaged around $8.9 million, with its median value being $8.7 million (2021).
  • Per our database at Business Quant, Neuroone Medical Technologies' Assets Average surged by 20708.32% in 2021 and then plummeted by 4947.97% in 2023.
  • Over the past 5 years, Neuroone Medical Technologies' Assets Average (Quarter) stood at $12.6 million in 2021, then decreased by 10.51% to $11.2 million in 2022, then tumbled by 38.09% to $7.0 million in 2023, then decreased by 14.77% to $5.9 million in 2024, then soared by 63.2% to $9.7 million in 2025.
  • Its last three reported values are $9.7 million in Q4 2025, $10.8 million for Q3 2025, and $7.6 million during Q2 2025.